Published online before print April 19, 2007, doi: 10.1161/01.RES.0000267723.65696.4a
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2007 American Heart Association, Inc.
Integrative Physiology |
Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
From the Cardiovascular Research Institute (R.R.A., S.G., P.Z., D.Z., S.F.V., J.S.), Department of Cell Biology and Molecular Medicine; Department of Biochemistry and Molecular Biology (B.T.), University of Medicine & Dentistry of New Jersey, New Jersey Medical School, Newark; and Oncology Research Institute (E.H., X.Y., T.W.), Greenville, SC.
Correspondence to Junichi Sadoshima, MD PhD, Cardiovascular Research Institute, UMDNJ, 185 S Orange Ave, MSB G609, Newark, NJ 07103. E-mail sadoshju{at}umdnj.edu
Silent information regulator (Sir)2, a class III histone deacetylase, mediates lifespan extension in model organisms and prevents apoptosis in mammalian cells. However, beneficial functions of Sir2 remain to be shown in mammals in vivo at the organ level, such as in the heart. We addressed this issue by using transgenic mice with heart-specific overexpression of Sirt1, a mammalian homolog of Sir2. Sirt1 was significantly upregulated (4- to 8-fold) in response to pressure overload and oxidative stress in nontransgenic adult mouse hearts. Low (2.5-fold) to moderate (7.5-fold) overexpression of Sirt1 in transgenic mouse hearts attenuated age-dependent increases in cardiac hypertrophy, apoptosis/fibrosis, cardiac dysfunction, and expression of senescence markers. In contrast, a high level (12.5-fold) of Sirt1 increased apoptosis and hypertrophy and decreased cardiac function, thereby stimulating the development of cardiomyopathy. Moderate overexpression of Sirt1 protected the heart from oxidative stress induced by paraquat, with increased expression of antioxidants, such as catalase, through forkhead box O (FoxO)-dependent mechanisms, whereas high levels of Sirt1 increased oxidative stress in the heart at baseline. Thus, mild to moderate expression of Sirt1 retards aging of the heart, whereas a high dose of Sirt1 induces cardiomyopathy. Furthermore, although high levels of Sirt1 increase oxidative stress, moderate expression of Sirt1 induces resistance to oxidative stress and apoptosis. These results suggest that Sirt1 could retard aging and confer stress resistance to the heart in vivo, but these beneficial effects can be observed only at low to moderate doses (up to 7.5-fold) of Sirt1.
Key Words: Sirt1 • aging • longevity factor • oxidative stress
Related Article:
Circ. Res. 2007 100: 1396-1398.
This article has been cited by other articles:
 |
|
 |
|
  N. Makino, T. Maeda, J.-i. Oyama, Y. Higuchi, and K. Mimori Improving insulin sensitivity via activation of PPAR-{gamma} increases telomerase activity in the heart of OLETF rats Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H2188 - H2195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Lu, I. Scott, B. R. Webster, and M. N. Sack The Emerging Characterization of Lysine Residue Deacetylation on the Modulation of Mitochondrial Function and Cardiovascular Biology Circ. Res., October 23, 2009; 105(9): 830 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-N. Li, J. Song, L. Zhang, S. A. LeMaire, X. Hou, C. Zhang, J. S. Coselli, L. Chen, X. L. Wang, Y. Zhang, et al. Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid-Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin Diabetes, October 1, 2009; 58(10): 2246 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-P. Hsu, S. Oka, D. Shao, N. Hariharan, and J. Sadoshima Nicotinamide Phosphoribosyltransferase Regulates Cell Survival Through NAD+ Synthesis in Cardiac Myocytes Circ. Res., August 28, 2009; 105(5): 481 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Boengler, R. Schulz, and G. Heusch Loss of cardioprotection with ageing Cardiovasc Res, July 15, 2009; 83(2): 247 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shan, Y. Wang, T. Wu, C. Liu, J. Guo, Y. Zhang, J. Liu, and Z. Xu Porcine sirtuin 1 gene clone, expression pattern, and regulation by resveratrol J Anim Sci, March 1, 2009; 87(3): 895 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tsutsui, S. Kinugawa, and S. Matsushima Mitochondrial oxidative stress and dysfunction in myocardial remodelling Cardiovasc Res, February 15, 2009; 81(3): 449 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Weidinger, K. Krause, A. Klagge, S. Karger, and D. Fuhrer Forkhead box-O transcription factor: critical conductors of cancer's fate Endocr. Relat. Cancer, December 1, 2008; 15(4): 917 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shinmura, K. Tamaki, and R. Bolli Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1 Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2348 - H2355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-Q. Tan, K. Wang, D.-Y. Lv, and P.-F. Li Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating Catalase J. Biol. Chem., October 31, 2008; 283(44): 29730 - 29739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Sundaresan, S. A. Samant, V. B. Pillai, S. B. Rajamohan, and M. P. Gupta SIRT3 Is a Stress-Responsive Deacetylase in Cardiomyocytes That Protects Cells from Stress-Mediated Cell Death by Deacetylation of Ku70 Mol. Cell. Biol., October 15, 2008; 28(20): 6384 - 6401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Pfluger, D. Herranz, S. Velasco-Miguel, M. Serrano, and M. H. Tschop Sirt1 protects against high-fat diet-induced metabolic damage PNAS, July 15, 2008; 105(28): 9793 - 9798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ventura-Clapier, A. Garnier, and V. Veksler Transcriptional control of mitochondrial biogenesis: the central role of PGC-1{alpha} Cardiovasc Res, July 15, 2008; 79(2): 208 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Griswold, K. T. Chang, A. P. Runko, M. A. Knight, and K.-T. Min Sir2 mediates apoptosis through JNK-dependent pathways in Drosophila PNAS, June 24, 2008; 105(25): 8673 - 8678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Csiszar, N. Labinskyy, A. Podlutsky, P. M. Kaminski, M. S. Wolin, C. Zhang, P. Mukhopadhyay, P. Pacher, F. Hu, R. de Cabo, et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2721 - H2735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Vakhrusheva, C. Smolka, P. Gajawada, S. Kostin, T. Boettger, T. Kubin, T. Braun, and E. Bober Sirt7 Increases Stress Resistance of Cardiomyocytes and Prevents Apoptosis and Inflammatory Cardiomyopathy in Mice Circ. Res., March 28, 2008; 102(6): 703 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Pillai, M. Chen, S. B. Rajamohan, S. Samant, V. B. Pillai, M. Gupta, and M. P. Gupta Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding-mediated induction of the {alpha}-myosin heavy chain expression Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1388 - H1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Papanicolaou, Y. Izumiya, and K. Walsh Forkhead Transcription Factors and Cardiovascular Biology Circ. Res., January 4, 2008; 102(1): 16 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sedding and J. Haendeler Do We Age on Sirt1 Expression? Circ. Res., May 25, 2007; 100(10): 1396 - 1398. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Guarente Sirtuins in Aging and Disease Cold Spring Harb Symp Quant Biol, January 1, 2007; 72(0): 483 - 488. [Abstract] [PDF]
|
|